Higher numbers of Foxp3+Tregs have been observed in the peripheral blood of cancer patients, in ascites, in the tumor microenvironment, and in tumor draining lymph nodes in a variety of solid cancers [9]. This evidence concerns the gene FOXP3 and neoplasm.